Back to discover
Disease

Endocarditis, Bacterial

Late-stage therapeutic developmentEmerging researchRising momentum
10
Publications
4
Clinical trials
6
Related conditions
2024
Latest publication
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this disease.

Evaluation of the Specificity of the 2023 Duke-International Society of Cardiovascular Infectious Diseases Classification for Infective Endocarditis.

Research2024-04-01Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

External Validation of the 2023 Duke-International Society for Cardiovascular Infectious Diseases Diagnostic Criteria for Infective Endocarditis.

Research2024-04-01Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

2023 ESC Guidelines for the management of endocarditis.

Research2023-10-01European heart journal

The 2023 Duke-International Society for Cardiovascular Infectious Diseases Criteria for Infective Endocarditis: Updating the Modified Duke Criteria.

Research2023-08-01Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

What's happening now

An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.

Clinical trials

4 sponsors · 0 new · 0 completed in the last 12 months (net +0)

The current development programme across all trial phases.

Research activity

10 papers

Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.

Publications over time
20062024
Most influential
Recent publications

External Validation of the 2023 Duke-International Society for Cardiovascular Infectious Diseases Diagnostic Criteria for Infective Endocarditis.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2024 · 33 cites

Evaluation of the Specificity of the 2023 Duke-International Society of Cardiovascular Infectious Diseases Classification for Infective Endocarditis.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2024 · 14 cites

2023 ESC Guidelines for the management of endocarditis.

European heart journal · 2023 · 1,026 cites
Major themes8
  • Endocarditis, Bacterial6
  • Endocarditis5
  • Communicable Diseases4
  • Heart Valve Prosthesis2
  • Bacteremia1
  • Cardiology1
  • Cardiovascular Diseases1
  • Prosthesis-Related Infections1
Leading journals5
  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America5
  • European heart journal2
  • Circulation1
  • Pathogens (Basel, Switzerland)1
  • The New England journal of medicine1
Leading researchers8
  • Durack DT3
  • Duval X3
  • Hoen B3
  • Karchmer AW3
  • Miro JM3
  • Selton-Suty C3
  • Baddour LM2
  • Bayer AS2
Affiliations (unnormalised)6
  • Duke University Medical Center3
  • Beth Israel Deaconess Medical Center2
  • Duke Clinical Research Institute2
  • Hospital Clinic-IDIBAPS2
  • Instituto de Salud Carlos III2
  • Mayo Clinic2

Related conditions

6 matches

Diseases frequently studied alongside this one. Number shows shared papers.

Disease profile

A grounded synthesis of the condition — overview, causes, mechanism, risk factors and current standard of care.

Overview

Bacterial endocarditis is an inflammation of the endocardium caused by bacteria that enter the bloodstream. It most commonly involves the endocardial surface of native or prosthetic heart valves.

Causes

The immediate cause is bacterial entry into the bloodstream followed by infection of the endocardium. The bacterial strains involved vary with predisposing factors, and the literature notes a shift in causative pathogens over time, with staphylococci now often overtaking streptococci as the main pathogens.

Pathophysiology

Bacteria in the bloodstream seed the endocardial surface, producing infection and inflammation of the endocardium. The disease commonly affects heart valves, including prosthetic valves, and diagnostic literature emphasizes imaging and microbiologic methods to detect this endocardial infection.

Risk factors

Predisposing factors include congenital heart defects, heart valve diseases, heart valve prosthesis implantation, and intravenous drug use. Review literature also identifies degenerative valvopathies and the presence of prosthetic heart valves as important risk factors.

Current standard of care

Management is described at the level of prevention, diagnosis, and therapy rather than specific regimens. The grounding supports prevention of infective endocarditis in high-risk settings, and treatment is generally antibiotic therapy guided by microbiology and diagnostic criteria; imaging modalities such as 18F-fluorodeoxyglucose PET and cardiac CT are used in diagnosis.

AI-generated summary grounded in MeSH and 3 peer-reviewed sources. Informational only — not medical advice. Generated 2026-07-07.

Reference

Authoritative identity, definition & identifiers.

Defined in MeSH

Inflammation of the ENDOCARDIUM caused by BACTERIA that entered the bloodstream. The strains of bacteria vary with predisposing factors, such as CONGENITAL HEART DEFECTS; HEART VALVE DISEASES; HEART VALVE PROSTHESIS IMPLANTATION; or intravenous drug use.

References & data sources
  • Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
  • Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
  • Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
  • Related entities are derived from literature co-mention (studied together) — associative, not causal.